LCP study members accumulated significantly more benefit-months than those on the low (LCP: 41.4 vs. Low: 6.4), childhood-limited (17.1), and adolescent-onset pathways (23.3). Despite comprising 9.0% of the cohort, they accounted for 24.7% of the total benefit-months accumulated by the study population.